Biopharmaceuticals Contract Manufacturing Market, 2022 to 2032- our new study reveals the latest industry trends, R&D progress, and predicted revenues
The U.S. is the Global Leader in Biopharmaceutical Business
The United States has been dubbed the life sciences innovation capital of the world, and it is a significant biopharmaceutical investor. The increased demand for biologics is likely to boost the expansion of the US biopharmaceuticals industry.
In terms of economic contributions and overall impacts, the biopharmaceutical sector in the United States is not only a worldwide leader in the development of innovative medicines, vaccines, and diagnostics, but it is also a highly valued industry. With a diverse employment base and vast research, manufacturing, and distribution infrastructure, the biopharmaceutical business in the United States is a major and innovative component of the country's economy, with considerable influence on economies around the country.
There is a vast innovation ecosystem in the biopharmaceutical industry that drives and maintains this success. An extensive network of collaborators supports the discovery, development, and delivery of new medicines to patients through this innovation ecosystem, which is led by both small and large R&D-intensive companies. This network includes but is not limited to venture and other forms of private capital; health care providers; public and private sector researchers including academic medical researchers and private research institutes; and various other sectors. A strong biopharmaceutical innovation ecosystem and innovation-based policy make the United States the world leader in biopharmaceutical innovation. All these factors are anticipated to fuel the biopharmaceutical contract manufacturing market in the United States.
COVID-19 pandemic has brought India’s Biopharmaceuticals Sector into the Limelight
The Indian biotechnology industry has entered a new phase of growth, with the rest of the world increasingly appreciating the sector's enormous potential to touch and improve people's lives. In the middle of the pandemic, the successful production of contingent commodities like the Covid-19 vaccine and indigenous diagnostic kits in such a brief period has been a wonderful benefit to humanity. The Biotechnology Industry Research and Development Corporation (BIRAC) and the Department of Biotechnology (DBT) have been at the forefront of enhancing the country's creative talents and potential.
The development of alternative Covid 19 solutions has been hastened by the Government of India's Mission program COVID Suraksha and the Covid-19 Research Consortium, which is led by DBT and BIRAC. With significant contributions from different states, the nation is on its way to becoming a globally renowned Innovation Hub and Biomanufacturing Hub. Official Biotech policies are in existence or being developed in several states. It is the responsibility of the Department of Biotechnology's Make In India (MII) Facilitation Cell, based at BIRAC alongside Invest India, to interact with States and assist them in formulating biotech policies, promote direct foreign investment, and improve the manufacturing sector, among other things.
What are the Market Driversw
• Rise in Investment by CMOs for Capacity Expansion
• Commercial success of biopharmaceuticals and consequent increase in demand for biopharmaceuticals
• Notable growth of biologics
• Robust biopharmaceuticals pipeline
• Cost and time-saving benefits offered by contract services
• Outsourcing as a Driver for Market Growth
• Growing Investments in Orphan Drugs
What are the Market Opportunities?
• Expansion of Fill and Finish CMOs
• Funding & investments
• Emerging Economies to Offer Lucrative Growth Opportunities
• Emergence of Single-Use Bioprocessing Equipment & Solutions
Discover how to stay ahead
Our 650+ page report provides 700+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biopharmaceuticals Contract Manufacturing Market. See how to exploit the opportunities.
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles, and commercial developments.
Discover sales predictions for the world market and sub-markets
Source
• Mammalian
• Non-mammalian
Service
• Process Development
- Downstream
- Upstream
• Fill & Finish Operations
• Analytical & QC studies
• Packaging
Product
• Biologics
- Monoclonal antibodies (MABs)
- Recombinant Proteins
- Vaccines
- Others
• Biosimilars
Company Size
• Small
• Mid-sized
• Large
Scale of Operations
• Preclinical
• Clinical
• Commercial
Region
• North America
• Europe
• Asia Pacific
• Latin America
• MEA
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:
By Region
North America
• U.S.
• Canada
Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• Southeast Asia
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Leading companies and the potential for market growth
Overall world revenue for Biopharmaceuticals Contract Manufacturing Market will surpass US$xx billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Biopharmaceuticals Contract Manufacturing Market report helps you
In summary, our 650+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Biopharmaceuticals Contract Manufacturing Market, with forecasts for 5 segmentations of the biopharmaceuticals contract manufacturing market, with forecasts for 2 Sources, 4 Services, 2 Products, 2 Company Size, and 3 Scale of Operations sub-segments each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 5 regional and 17 key national markets– See forecasts for the Biopharmaceuticals Contract Manufacturing market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 18 of the companies involved in the Biopharmaceuticals Contract Manufacturing Market. Some of the companies profiled in this report include AbbVie, Inc., AGC Biologics, Avantor, Binex Co., Ltd., Boehringer Ingelheim GmbH, Cambrex Corporation, Curia Global, Inc., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., JRS PHARMA, Jubilant Pharma Limited, Lonza, Pfizer CentreOne, ProBioGen, Rentschler Biopharma SE, Samsung Biologics, Sandoz, TOYOBO CO., LTD., Thermo Fisher Scientific, and WuXi Biologics, among other prominent players.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Biopharmaceuticals Contract Manufacturing Market and leading companies. You will find data, trends, and predictions.
'
1. Report Overview
1.1 Introduction to Biopharmaceuticals Contract Manufacturing Market
1.2 Biopharmaceuticals Contract Manufacturing Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
2.1 Regional Analysis, 2022
2.2 Opportunities
2.3 Emerging Outsourcing Trends in Biopharmaceuticals
2.4 Demand for RNA-based COVID-19 Vaccines Creates Revenue Opportunities for Contact Manufacturers
2.5 Increase in Investment in Research & Development
2.6 Analyst Viewpoint
3 Market Dynamics
3.1 Drivers
3.1.1 Rise in Investment by CMOs for Capacity Expansion
3.1.2 Cost and Time Saving Benefits Offered by Contract Services
3.1.3 Outsourcing as a Driver for Market Growth
3.1.4 Growing Investments in Orphan Drugs
3.2 Restraints
3.2.1 Pricing Pressure to Impede Market Growth Through 2031
3.2.2 Regulatory Scenarios to Restrain Market Growth
3.2.3 Excessive Production is Projected to Impede Market Growth
3.3 Opportunities
3.3.1 Expansion of Fill-and-Finish CMOs
3.3.2 Emergence of Single-Use Bioprocessing Equipment & Solutions
3.3.3 Emerging Economies to Offer Lucrative Growth Opportunities
3.4 Impact of COVID-19 on Biopharmaceutical Contract Manufacturing Market
3.5 SWOT Analysis
3.5.1 Strengths
3.5.2 Weaknesses
3.5.3 Opportunities
3.5.4 Threats
3.6 Porter’s Five Forces Analysis
3.6.1 Buyer Power of Suppliers (Low)
3.6.2 Supplier Power (Medium)
3.6.3 Competitive Rivalry (High)
3.6.4 Threat of Substitute (Medium)
3.6.5 Threat of New Entrants (Low)
3.7 PEST Analysis
3.7.1 Political Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.7.2 Economic Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.7.3 Social Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.7.4 Technological Factors Impacting Biopharmaceuticals Contract Manufacturing Market
4 Biopharmaceuticals Contract Manufacturing Market by Source
4.1 Mammalian Segment Market Forecast, 2022-2032
4.1.1 Segment Overview
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Non-mammalian Segment Market Forecast, 2022-2032
4.2.1 Segment Overview
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Biopharmaceuticals Contract Manufacturing Market by Service
5.1 Process Development Segment Market Forecast, 2022-2032
5.1.1 Upstream Process Development
5.1.2 Downstream Process Development
5.1.3 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Fill & Finish Operations Segment Market Forecast, 2022-2032
5.2.1 Segment Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 Analytical & QC Studies Segment Market Forecast, 2022-2032
5.3.1 Segment Overview
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 Packaging Segment Market Forecast, 2022-2032
5.4.1 Segment Overview
5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Biopharmaceuticals Contract Manufacturing Market by Product
6.1 Biologics Segment Market Forecast, 2022-2032
6.1.1 Segment Overview
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Biosimilars Segment Market Forecast, 2022-2032
6.2.1 Segment Overview
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Biopharmaceuticals Contract Manufacturing Market by Company Size
7.1 Small Segment Market Forecast, 2022-2032
7.1.1 Segment Overview
7.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 Mid-sized Segment Market Forecast, 2022-2032
7.2.1 Segment Overview
7.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Large Segment Market Forecast, 2022-2032
7.3.1 Segment Overview
7.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 Biopharmaceuticals Contract Manufacturing Market by Scale of Operations
8.1 Preclinical Segment Market Forecast, 2022-2032
8.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.2 Clinical Segment Market Forecast, 2022-2032
8.2.1 Segment Overview
8.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.3 Commercial Segment Market Forecast, 2022-2032
8.3.1 Segment Overview
8.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 Regional and Leading National Biopharmaceuticals Contract Manufacturing Market Forecasts 2022-2032
9.1 Global Biopharmaceuticals Contract Manufacturing Market by Region Forecast 2022-2032
9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
10 North America Biopharmaceuticals Contract Manufacturing Market
10.1 Regional Overview
10.2 North America Biopharmaceuticals Contract Manufacturing Market by Country, Forecast 2022-2032
10.3 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source
10.4 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service
10.5 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product
10.6 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size
10.7 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations
10.8 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
10.8.1 Market Overview
10.8.2 Global Leader in Biopharmaceutical Business
10.8.3 U.S. Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
10.8.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
10.9 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
10.9.1 Market Overview
10.9.2 Collaborations Among Players to Fuel Canadian Biopharmaceutical Contract Manufacturing Market
10.9.3 Canada Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
10.9.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11 Europe Biopharmaceuticals Contract Manufacturing Market
11.1 Regional Overview
11.2 Europe Biopharmaceuticals Contract Manufacturing Market by Country, Forecast 2022-2032
11.3 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source
11.4 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service
11.5 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product
11.6 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size
11.7 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations
11.8 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.8.1 Germany to Witness Highest Growth Rate Across European Region
11.8.2 Market Overview
11.8.3 COVID-19 Impact Analysis
11.8.4 Germany Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
11.8.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.9 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.9.1 Significant Biopharmaceutical Contribution
11.9.2 Market Overview
11.9.3 UK Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
11.9.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.10 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.10.1 Robust Pipeline to Fuel Market Growth
11.10.2 Growing Initiatives by Established Firms to Boost Market Growth
11.10.3 France Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
11.10.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.11 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.11.1 Role of CDMO Business Across Italy
11.11.2 Investment by Major Players to Fuel Market Expansion
11.11.3 Italy Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
11.11.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.12 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.12.1 Spain Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
11.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.13 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
11.13.1 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
11.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12 Asia Pacific Biopharmaceuticals Contract Manufacturing Market
12.1 Regional Overview
12.2 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Country, Forecast 2022-2032
12.3 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source
12.4 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service
12.5 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product
12.6 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size
12.7 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations
12.8 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.8.1 Bushu expects to double the volume of Amgen drugs it makes under new Asia CMO pact
12.8.2 Japan Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
12.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.9 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.9.1 Domestic Drug Innovation on Rise
12.9.2 SK Biopharmaceuticals Enters Greater China Out-Licensing 6 Clinical Pipelines to CNS-Focused Biotech Ignis Therapeutics
12.9.3 Strong Growth Provides CMO Opportunities
12.9.4 China Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
12.9.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.10 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.10.1 The COVID-19 pandemic has brought India’s biotechnology industry, especially biopharmaceuticals into the limelight
12.10.2 Piramal Pharma Ltd. Invests Minority Stake in CDMO Yapan Bio
12.10.3 India Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
12.10.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.11 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.11.1 BioCina Expands into Full-service mRNA CDMO
12.11.2 Australia Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
12.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.12 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.12.1 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
12.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Southeast Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.13 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
12.13.1 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
12.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
13 Latin America Biopharmaceuticals Contract Manufacturing Market
13.1 Regional Overview
13.2 Latin America Biopharmaceuticals Contract Manufacturing Market by Country, Forecast 2022-2032
13.3 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source
13.4 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service
13.5 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product
13.6 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size
13.7 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations
13.8 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
13.8.1 Brazil Driving the Latin America Biopharmaceutical Contract Manufacturing Market
13.8.2 Growing Pharmaceutical Sector to Fuel Market Growth
13.8.3 Brazil Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
13.8.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
13.9 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
13.9.1 Mexico is a Key Player in Biotechnology
13.9.2 Mexico Targets a Group of Indian Generics Makers for Homeland Pharma Hub
13.9.3 Mexico Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
13.9.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
13.10 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
13.10.1 Argentina Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
13.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
13.11 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
13.11.1 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
13.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
14 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market
14.1 Regional Overview
14.2 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market by Country, Forecast 2022-2032
14.3 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast by Source
14.4 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast by Service
14.5 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast by Product
14.6 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size
14.7 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations
14.8 GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
14.8.1 Pharmaceutical Market Across GCC
14.8.2 Growing Investment to Fuel Market Expansion
14.8.3 Mubadala teams up with G42 to set up a biopharma manufacturing campus in Abu Dhabi
14.8.4 GCC Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
14.8.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
14.9 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
14.9.1 South African Evolving Demographic and Epidemiological Profile to Offer Lucrative Growth Prospects
14.9.2 South Africa Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
14.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
14.10 Rest of Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
14.10.1 Introduction
14.10.2 Rest of Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Revenue, 2022-2032
14.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2022-2032
15 Company Profiles
15.1 AbbVie, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.3.1 Net Revenue, 2015-2020
15.1.3.2 R&D Expenses, 2015-2020
15.1.3.3 Gross Profit, 2015-2020
15.1.4 Product Benchmarking
15.1.5 Recent Developments till December 2021
15.2 AGC Biologics
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Product Benchmarking
15.2.4 Recent Developments till December 2021
15.3 Avantor
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2020
15.3.3.2 Gross Profit, 2017-2020
15.3.4 Product Benchmarking
15.3.5 Recent Developments till December 2021
15.4 Binex Co., Ltd.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Product Benchmarking
15.5 Boehringer Ingelheim GmbH
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2015-2020
15.5.4 Product Benchmarking
15.5.5 Recent Developments till December 2021
15.6 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Product Benchmarking
15.6.4 Recent Developments till December 2021
15.7 Lonza
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2015-2020
15.7.3.2 R&D Expenses, 2017-2020
15.7.3.3 Gross Profit, 2015-2020
15.7.4 Product Benchmarking
15.7.5 Recent Developments till December 2021
15.8 ProBioGen
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Product Benchmarking
15.8.4 Recent Developments till January 2022
15.9 Rentschler Biopharma SE
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Product Benchmarking
15.9.4 Recent Developments till December 2021
15.10 Samsung BioLogics
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Product Benchmarking
15.10.4 Recent Developments till December 2021
15.11 Sandoz
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2015-2020
15.11.4 Product Benchmarking
15.11.5 Recent Developments till December 2021
15.12 TOYOBO CO., LTD.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Product Benchmarking
15.13 WuXi Biologics
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2015-2020
15.13.3.2 Gross Profit, 2015-2020
15.13.4 Product Benchmarking
15.13.5 Recent Developments till January 2022
15.14 JRS PHARMA
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Product Benchmarking
15.14.4 Recent Developments till January 2022
15.15 Thermo Fisher Scientific
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2015-2020
15.15.3.2 R&D, 2015-2020
15.15.3.3 Gross Profit, 2015-2020
15.15.4 Product Benchmarking
15.16 Cambrex Corporation
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Product Benchmarking
15.16.4 Recent Developments till January 2022
15.17 Curia Global, Inc.
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Product Benchmarking
15.17.4 Recent Developments till January 2022
15.18 Pfizer CentreOne
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2015-2020
15.18.3.2 R&D, 2015-2020
15.18.3.3 Gross Profit, 2015-2020
15.18.4 Product Benchmarking
15.19 Jubilant Pharma Limited
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Product Benchmarking
16 Conclusion and Recommendations
16.1 Concluding Remarks
16.2 Recommendations
16.3 Leading Biopharmaceuticals Contract Manufacturing Market by Region
List of Tables
Table 1 Global Biopharmaceuticals Contract Manufacturing Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 3 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mammalian Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 4 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mammalian Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mammalian Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mammalian Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mammalian Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Non-mammalian Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 9 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Non-mammalian Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Non-mammalian Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Non-mammalian Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Non-mammalian Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 14 Summary of upstream process development activities by clinical stages
Table 15 Summary of downstream process development activities by clinical stages
Table 16 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Process Development, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 17 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Process Development, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 18 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Process Development, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 19 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Process Development, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 20 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Process Development, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 21 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Fill & Finish Operations Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 22 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Fill & Finish Operations Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 23 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Fill & Finish Operations Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 24 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Fill & Finish Operations Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 25 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Fill & Finish Operations Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 26 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Analytical & QC Studies Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 27 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Analytical & QC Studies Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 28 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Analytical & QC Studies Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 29 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Analytical & QC Studies Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 30 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Analytical & QC Studies Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 31 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Packaging Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 32 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Packaging Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 33 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Packaging Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 34 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Packaging Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 35 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Packaging Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 36 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 37 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 38 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 39 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 40 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 41 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 42 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Biosimilars Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 43 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Biosimilars Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 44 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Biosimilars Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 45 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Biosimilars Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 46 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Biosimilars Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 47 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 48 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Small Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 49 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Small Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 50 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Small Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 51 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Small Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 52 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Small Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 53 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mid-sized Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 54 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mid-sized Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 55 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mid-sized Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 56 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mid-sized Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 57 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Mid-sized Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 58 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Large Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 59 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Large Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 60 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Large Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 61 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Large Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 62 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Large Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 63 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 64 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Preclinical Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 65 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Preclinical Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 66 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Preclinical Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 67 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Preclinical Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 68 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Preclinical Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 69 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Clinical Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 70 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Clinical Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 71 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Clinical Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 72 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Clinical Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 73 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Clinical Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 74 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Commercial Segment, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 75 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Commercial Segment, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 76 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Commercial Segment, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 77 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Commercial Segment, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 78 Global Biopharmaceuticals Contract Manufacturing Market Forecast for Commercial Segment, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 79 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 80 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 81 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 82 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 83 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 84 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 85 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 86 North America Biopharmaceuticals
